Routine Genital Herpes Serologic Testing Not Recommended: USPSTF Reaffirms

Published Date: 17 Feb 2023

United States: The USPSTF advised against serological testing for the genital herpes simplex virus (HSV) in an advisory...

Read Full News

Latest News

J&J Reaches Sweeping Talc Deal That Could End Decade Of Litigation

(This July 27 story has been republished, with no change to text)

US Judge Says Biden-era Restrictions on Prescribing Abortion Drug Are Unlawful

A federal judge in Virginia has ruled that it was illegal for former President Joe Biden's administration to require doctors and pharmacies to be ⁠specially certified to...

Severe Preeclampsia Mapped in Affected Tissues in New Study

Severe preeclampsia appears to involve tissues far beyond the placenta, according to a new study that provides one of the most detailed cellular maps of the condition to date.

Indigenous Canadians Mistreated During Childbirth

Nearly two thirds of Indigenous Canadians surveyed report experiencing mistreatment and disrespect during pregnancy and childbirth.

Ischemic Placental Disease Tied to Postpartum Brain Risks

Pregnancies complicated by ischemic placental disease are associated with a higher risk for hospital admissions for brain disorders in the year after delivery, a study finds.

In Maternal Health Deserts, Pharmacists Are Bridging Gaps

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Latest News

(This July 27 story has been republished, with no change to text)

A federal judge in Virginia has ruled that it was illegal for former President Joe Biden's administration to require doctors and pharmacies to be ⁠specially certified to...

Severe preeclampsia appears to involve tissues far beyond the placenta, according to a new study that provides one of the most detailed cellular maps of the condition to date.

Nearly two thirds of Indigenous Canadians surveyed report experiencing mistreatment and disrespect during pregnancy and childbirth.

Pregnancies complicated by ischemic placental disease are associated with a higher risk for hospital admissions for brain disorders in the year after delivery, a study finds.

To address high rates of maternal and infant mortality and morbidity, pharmacists in Mississippi are stepping in to provide care and connect women with obstetric care.

News All Time

Medicaid Funding Resumes for Planned Parenthood After Halting for Most of a Year

Some services are returning but others may not

Hospital Under Investigation; 4,000 Nurses Strike; Fentanyl Makers Pivot to Peptides

Health news and commentary gathered by MedPage Today staff

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Translating Risk Into Tailored Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Advancing TNBC Care: Clinical Insights and Effective Application of Emerging Treatment Strategies Across Lines of Therapy

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Molecular Matters: Next-Gen Sequencing, Liquid Biopsy, and the Future of ctDNA Applications

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Rewiring Resistance: Precision Sequencing and Mechanism-Driven Care in Platinum-Resistant Ovarian Cancer

Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization

"This is real protection, and it really applies to all comers," researcher says

What Vitamin K Shot Refusals Are Really Telling Us

We can't fact-check our way out of a trust crisis

Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo

Experts discuss Prosigna-guided treatment decisions in high-risk early disease

Optimizing Perioperative Therapy in Triple-Negative Breast Cancer

The treatment landscape for these patients is evolving

Tailoring Treatment for Triple-Negative Breast Cancer in Older Patients

"Most of the time we undertreat," says expert

ACOG Makes Vaccine Recommendations for the First Time

A look at how the recommendations differ from the CDC

They Told Families to 'Eat Real Food.' Now They May Cut the Produce Benefit.

To make America healthy, produce in a poor child's diet should be the last thing to go

Upcoming Billing Change Could Make Pregnancy Pricier

ACOG says the change is crucial to accurately reflect the care ob/gyns currently provide

Trump's 22 Medical Specialists; Infectious Hot Tub; Ending Postpartum Hemorrhage

Health news and commentary gathered by MedPage Today staff

Drinking in Pregnancy on the Rise, CDC Data Show

Expert urges public health campaigns to share the dangers of alcohol use in pregnancy

Recommended News For You

Microplastics can cause malignant changes in lung cells

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

BMI is linked to heart damage from chemotherapy in breast cancer patients.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Recommended Articles For You

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends 

Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights 

Uncovering the Mystery of the Sessile Serrated Adenoma 

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

2.

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

3.

Second opinions don't significantly delay breast cancer treatment

4.

Year in Review: Multiple Myeloma

5.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

1.

The importance of understanding normal serum osmolality

2.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

3.

What is Red Cell Distribution Width and Why Should You Care?

4.

Metabolic Vulnerabilities in Solid Tumor Progression

5.

Exploring the Normal Range of Monocytes: A Comprehensive Guide

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot